- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Adaptogenics Health Corp (2): Adaptogenics has strategy to acquire peptide assets | 1 | Stockwatch | ||
| Mo | Adaptogenics Announces Strategy to Build Proprietary Peptide Assets and Delivery Technologies | 2 | CNW | ||
| 14.10. | Adaptogenics Health Corp (2): Adaptogenics Health appoints Nabhan as president | 1 | Stockwatch | ||
| 13.10. | Adaptogenics Health Corp.: Adaptogenics Appoints Antoun Nabhan as President | 1 | TheNewswire | ||
| 08.10. | Adaptogenics Health Corp (2): Adaptogenics buys research assets for GLP-1 line | 1 | Stockwatch | ||
| ADAPTOGENICS HEALTH Aktie jetzt für 0€ handeln | |||||
| 08.10. | Adaptogenics Health Corp.: Adaptogenics Acquires Nutritional Research Assets to Advance GLP-1 Companion Initiative | 1 | TheNewswire | ||
| 02.10. | Adaptogenics Health Corp (2): Adaptogenics Health appoints Warren as CEO | 1 | Stockwatch | ||
| 02.10. | Adaptogenics Health Corp.: Adaptogenics Appoints Accomplished Peptide Scientist Dr. J. David Warren as Chief Executive Officer | 583 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - October 2, 2026) - Adaptogenics Health Corp. (CSE: ADPT) ("Adaptogenics" or the "Company") is pleased to announce the appointment of J. David Warren, Ph.D.... ► Artikel lesen | |
| 29.09. | Adaptogenics Health Corp (2): Adaptogenics Health closes $327,000 private placement | 4 | Stockwatch | ||
| 28.09. | Adaptogenics Health closes oversubscribed private placement | 2 | Investing.com | ||
| 28.09. | Adaptogenics Health schließt überzeichnete Privatplatzierung ab | - | Investing.com Deutsch | ||
| 28.09. | Adaptogenics Health Corp.: Adaptogenics Health Corp. Announces Closing of Over Subscribed Non-Brokered Private Placement | 366 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - September 28, 2026) - Adaptogenics Health Corp. (CSE: ADPT) ("Adaptogenics", the "Company") is pleased to announce that, further to its news release dated... ► Artikel lesen | |
| 15.08. | Adaptogenics Health Corp (2): Adaptogenics Health arranges $320,000 financing | 1 | Stockwatch | ||
| 15.08. | Adaptogenics Health Corp.: Adaptogenics Health Corp. Announces Non-Brokered Private Placement | 979 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - August 14, 2026) - Adaptogenics Health Corp. (CSE: ADPT) ("Adaptogenics", the "Company") is pleased to announce it is launching a non-brokered private... ► Artikel lesen | |
| 07.08. | Adaptogenics Health Corp.: Adaptogenics Health Corp. Announces Change of Directors | 700 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - August 6, 2026) - Adaptogenics Health Corp. (CSE: ADPT) ("Adaptogenics", the "Company") is pleased to announce the appointment of Mr. Gurinder Sandhu... ► Artikel lesen | |
| 14.07. | Adaptogenics Health Corp.: Adaptogenics Health Corp. Announces Effective Date of Share Consolidation | 540 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - July 14, 2026) - Adaptogenics Health Corp. (CSE: ADPT) ("Adaptogenics", the "Company") is pleased to announce that the Canadian Securities Exchange... ► Artikel lesen | |
| 13.07. | Adaptogenics Health Corp (1): Adaptogenics Health 1:4 rollback | 2 | Stockwatch | ||
| 13.07. | CSE Bulletin: Consolidation - Adaptogenics Health Corp. (ADPT) | 486 | Newsfile | Le 13 juillet/July 2026
Adaptogenics Health Corp. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated share for four (4) pre-consolidated... ► Artikel lesen | |
| 09.07. | Adaptogenics Health Corp: Adaptogenics to roll back shares 1:4 | 1 | Stockwatch | ||
| 09.07. | Adaptogenics Health Corp.: Adaptogenics Health Corp. Announces Share Consolidation | 583 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - July 8, 2026) - Adaptogenics Health Corp. (CSE: ADPT) ("Adaptogenics", the "Company") announces that it intends to consolidate the common shares of... ► Artikel lesen |
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 43,480 | +0,18 % | Frist statt Freibrief: Was der EU-Pestizidbeschluss für Bayer, BASF und MustGrow Biologics bedeutet | Erstellt und veröffentlicht im Auftrag von MustGrow Biologics. Der Rat der Europäischen Union positionierte sich am 30. September 2026 gegen unbefristete Zulassungen für synthetische Pflanzenschutzmittel... ► Artikel lesen | |
| MERCK KGAA | 146,40 | +1,42 % | Aktie wird zerlegt: BioNTech verfehlt Krebsziel - aber leben Patienten mit der Therapie länger? | © Foto: picture alliance / Laci Perenyi | Laci PerenyiDas erste Hauptziel der Krebsstudie ist verfehlt. Doch die entscheidende Frage bleibt offen: Kann BNT113 das Leben der Patienten verlängern Enthaltene... ► Artikel lesen | |
| TEVA PHARMACEUTICAL INDUSTRIES | 40,870 | +0,04 % | Teva: Uvakitug Maintains Meaningful Efficacy Improvements In Long-term Extension Study | PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries (TEVA), and Sanofi announced new positive data from the RELIEVE UCCD phase 2b long-term extension... ► Artikel lesen | |
| IAMBIC THERAPEUTICS | 16,000 | -0,06 % | Biotech an der Börse: Iambic-IPO bringt 150 Millionen USD für Krebsmedikamente | Das US-Biotechunternehmen Iambic setzt bei neuen Krebsmedikamenten auf künstliche Intelligenz. Mit dem frischen Börsenkapital will es klinische Studien voranbringen und seine Forschungstechnik ausbauen.... ► Artikel lesen | |
| KARDIGAN | 13,510 | 0,00 % | Kardigan stock initiated at Outperform by William Blair on pipeline | ||
| SCHOTT PHARMA | 26,000 | +1,96 % | SCHOTT Pharma mit PAUKENSCHLAG: Kaufen Insider bereits massiv? - Unbedingt noch vor Börsenschluss lesen! | ||
| ETON PHARMACEUTICALS | 50,15 | -0,08 % | Eton Pharmaceuticals Lands Exclusive US Rights To Aquestive's Seizure Rescue Drug | ||
| OMNIAB | 4,955 | 0,00 % | OmniAb auf der LD Micro Konferenz: Lizenzgebühren, Skalierung und Geduld im Fokus | ||
| AQUESTIVE THERAPEUTICS | 4,060 | +0,25 % | H.C. Wainwright bekräftigt Kaufempfehlung für Aquestive nach FDA-Fortschritten | ||
| BIOHAVEN | 11,805 | -0,13 % | Biohaven Ltd. - 8-K, Current Report | ||
| LB PHARMACEUTICALS | 41,000 | 0,00 % | LB Pharmaceuticals Inc: LB Pharmaceuticals to Participate in Upcoming Investor Events | ||
| GENERATE BIOMEDICINES | 12,905 | +0,04 % | Generate Biomedicines Lands Major AI Drug Partnership to Target Booming Obesity Market | ||
| BRIGHT MINDS BIOSCIENCES | 55,21 | 0,00 % | Levoit and Cosori: 5 Back to School Wellness Heroes for the Bright Minds of Tomorrow | DUBAI, UAE, Aug. 21, 2026 /PRNewswire/ -- Levoit and Cosori unveil five smart home solutions to tackle back to school stresses: polluted indoor air, relentless AC dryness, post snack floor... ► Artikel lesen | |
| SEAPORT THERAPEUTICS | 19,240 | -0,21 % | Seaport Therapeutics, Inc.: Seaport Therapeutics Presents Additional Pharmacokinetic Data from Phase 1 Clinical Trial of GlyphAgo at the 39th European College of Neuropsychopharmacology (ECNP) Congress | First scientific presentation of detailed PK data demonstrates dose-dependent increases in agomelatine exposure, no food effect, and no accumulation of exposure over seven days of dosing Detailed... ► Artikel lesen | |
| APNIMED | 18,530 | +0,11 % | Apnimed, Inc.: Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update | U.S. Food and Drug Administration ("FDA") Accepted the NDA for AD109, with a proposed proprietary name Oxnimbi- and assigned a PDUFA target action date of February 28,- 2027 If approved, Oxnimbi... ► Artikel lesen |
ADAPTOGENICS HEALTH CORP gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ADAPTOGENICS HEALTH CORP finden Sie auf Wallstreet Online.